Tuesday was a bullet-dodging day for Pristine Solutions, Inc. (PRTN) who was set to receive an “E” to their ticker on the 20th for delinquent filing. The notice issued which could have meant ineligibility for quotation and subject to removal from the OTCBB in 30 calendar days was averted at the end of the day when they filed the required documentation from their Form S-1/A. The yield sign issued to PRTN stock via OTCMarkets on Saturday could still be attached since the 10-Q due date for the three months ended July 31 is Thursday.
Our New Alert Is Set For September 25th! Click HERE To Make Sure You Don’t Miss It!
PRTN Stock Chart
Market Cap: 204.82M
Close: 0.49, up 0.057 (13.16%)
Dollar Volume: $5,593,185
Average Trade Size: 8,924
% Gain Since August 24: 117.78%
Issued and Outstanding:
Looking for Hot Penny Stocks?
Click here and get Alerts on the Best Penny Stocks FREE
Tuesday’s close marked the 17th trading session for the Awesome Penny Stocks promotion, roughly half way based on their NSRS and SNPK runs. The performance of PRTN has been about as exciting as GWBU was, like a toothpick stuck in your teeth just after leaving the dentist office. Yet, with the recent events of stocks getting suspended, thanks to the SEC in Washington and the SEC Enforcement Division in Miami, the name tagging of Dr. Jennifer R. Berman, MD, who is supposed to appear on The Ricki Lake Show as women’s sexual health expert, looks like the aces are out and its time to either call or fold.
With the name attachment, which investors should note have yet to include a comment by Dr. Berman herself or any spokesperson on her behalf, as well as the magical ability for Tropine 3 to achieve FDA approval after clinical trials are completed, all the stops have been pulled. It has become such a sloppy mess that the banner for Pristine Solutions landing page was even hosted on the website of the pump and dumpers as of Tuesday.
With no hard mailers known of, the focus now is on when, not if, PRTN stock crashes.
About PRTN Stock
Pristine Solutions, Inc., through its wholly-owned subsidiary company, Eaton Scientific Systems, Ltd., holds the intellectual property and global marketing rights to Tropine 3, a patent pending novel indication of an existing FDA approved drug for the non-hormonal treatment of hot flashes in pre-menopausal, peri-menopausal, and post-menopausal women. The company is preparing for Phase 1 & 2 Clinical Trials with the goal of FDA approval of Tropine 3.
Bottom Line: The awesome penny stocks pump and dump of PRTN is less profitable for traders willing to risk capital than GWBU was. Even if PRTN was to make a run, with the amount of money stolen from traders with their last penny stock alert, VLNX, it is amazing that anyone is still playing it considering all of the opportunities out there. Further proof that due diligence sounds too much like homework, and how email alerts are the cliff notes version of a stock tip.
Here is your opportunity to subscribe to the Most Read Penny Stock Newsletter
If You Can’t Make Money With Us, You Shouldn’t Be Trading Penny Stocks
(We are 100% Anti-Spam and will never rent or sell your information)Share